Diabetes technology

Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions

Diabetes Technol TherPublished Secondary analysis of the HARPdoc randomised trial

Authors' conclusion

Psychoeducation (BGAT and HARPdoc) was effective in reducing SH in people using ADTs. HARPdoc may also provide greater long-term SH reduction and improves psychological well-being in this patient group.

Study context

Population
People with T1D and problematic hypoglycemia persisting despite optimized care, using advanced diabetes technologies (CGM or AID)
Participants
45 ADT users
Comparison
HARPdoc vs Blood Glucose Awareness Training (BGAT)
Primary endpoint
Severe hypoglycemia (SH) incidence
Methodological detailssubgroup analysis
  • Subgroup analysis

Primary result

As reported in the abstract

SH incidence
BGAT and HARPdoc both reduced severe hypoglycemia (SH) incidence by more than 50%
P < 0.0001

Further findings

Hypoglycemia awareness (Gold questionnaire)

Both interventions improved hypoglycemia awareness
P < 0.05

Unhelpful hypoglycemia beliefs (A2A), diabetes distress (Problem Areas in Diabetes (PAID)), anxiety (Hospital Anxiety and Depress Scale (HADS)-anxiety)

HARPdoc mitigated unhelpful hypoglycemia beliefs
P < 0.0001
HARPdoc mitigated diabetes distress
P < 0.05
HARPdoc mitigated anxiety symptoms
P < 0.05
BGAT demonstrated no significant impacts in these respects

Depression symptoms (HADS-depression)

Neither HARPdoc nor BGAT had significant effects on depression symptoms

Original publication

Mitigating Severe Hypoglycemia in Users of Advanced Diabetes Technologies: Impaired Awareness of Hypoglycemia and Unhelpful Hypoglycemia Beliefs as Targets for Interventions. Diabetes Technol Ther. Published 29 April 2024. doi:10.1089/dia.2024.0039

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.